Employees: 00 (2023.0)Legal category: 5485Size: PMECreation date: 2016-08-31 (9 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: HORDAIN (59111), Nord
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE ROMMES : revenue, balance sheet and financial ratios
PHARMACIE ROMMES is a French company
founded 9 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in HORDAIN (59111),
this company of category PME
shows in 2022 a revenue of 1.4 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE ROMMES (SIREN 822936084)
Indicator
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
1 432 215 €
N/C
N/C
N/C
N/C
N/C
Net income
562 558 €
135 735 €
105 618 €
133 023 €
97 329 €
97 613 €
101 041 €
EBITDA
N/C
183 599 €
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
9.5%
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2023, PHARMACIE ROMMES generates positive net income of 563 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2023: 101 k€ -> 563 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
562 558 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 22%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 75%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
21.859%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
74.581%
Solvency indicators evolution PHARMACIE ROMMES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
Debt ratio
244.948
149.811
101.414
67.247
52.017
38.265
21.859
Financial autonomy
24.302
36.216
43.004
52.812
59.314
64.428
74.581
Repayment capacity
None
None
None
None
None
2.068
None
Cash flow / Revenue
None%
None%
None%
None%
None%
9.862%
None%
Sector positioning
Debt ratio
21.862023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Good-9 pts over 3 years
In 2023, the debt ratio of PHARMACIE ROMMES (21.86) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
74.58%2023
2021
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Excellent+6 pts over 3 years
In 2023, the financial autonomy of PHARMACIE ROMMES (74.6%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
2.07 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Good
In 2022, the repayment capacity of PHARMACIE ROMMES (2.07) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 1096.93. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
1096.934
Liquidity indicators evolution PHARMACIE ROMMES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
Liquidity ratio
223.473
383.589
323.804
414.354
534.372
531.58
1096.934
Interest coverage
None
None
None
None
None
1.699
None
Sector positioning
Liquidity ratio
1096.932023
2021
2022
2023
Q1: 135.25
Med: 189.78
Q3: 270.35
Excellent
In 2023, the liquidity ratio of PHARMACIE ROMMES (1096.93) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
1.7x2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Average
In 2022, the interest coverage of PHARMACIE ROMMES (1.7x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2023)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2023)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2023)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2023)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE ROMMES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
Operating WCR
0 €
0 €
0 €
0 €
0 €
172 167 €
0 €
Inventory turnover (days)
0
0
0
0
0
25
0
Customer payment term (days)
0
0
0
0
0
8
0
Supplier payment term (days)
0
0
0
0
0
36
0
Positioning of PHARMACIE ROMMES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of PHARMACIE ROMMES is estimated at
6 637 889 €
(range 4 036 818€ - 9 331 383€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
4036k€6637k€9331k€
6 637 889 €Range: 4 036 818€ - 9 331 383€
NAF 5 année 2023
Valuation method used
Net Income Multiple
562 558 €
×
11.8x
=6 637 890 €
Range: 4 036 818€ - 9 331 383€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE ROMMES with other companies in the same sector:
The revenue of PHARMACIE ROMMES in 2022 is 1.4 M€.
Is PHARMACIE ROMMES profitable?
Yes, PHARMACIE ROMMES generated a net profit of 563 k€ in 2023.
Where is the headquarters of PHARMACIE ROMMES ?
The headquarters of PHARMACIE ROMMES is located in HORDAIN (59111), in the department Nord.
Where to find the tax return of PHARMACIE ROMMES ?
The tax return of PHARMACIE ROMMES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE ROMMES operate?
PHARMACIE ROMMES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart